Elutia Inc.ELUTNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank71
5Y CAGR-41.7%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

5Y CAGR
-41.7%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive growthRecovering
PeriodValue
20259.99%
2024-13.96%
2023-43.07%
2022-16.61%
202155.63%
2020148.08%
2019-3.26%
20180.00%